NM_000334.4:c.612-94G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000334.4(SCN4A):​c.612-94G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.351 in 747,310 control chromosomes in the GnomAD database, including 49,332 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 8267 hom., cov: 30)
Exomes 𝑓: 0.36 ( 41065 hom. )

Consequence

SCN4A
NM_000334.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.38

Publications

18 publications found
Variant links:
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
SCN4A Gene-Disease associations (from GenCC):
  • hyperkalemic periodic paralysis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • paramyotonia congenita of Von Eulenburg
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • SCN4A-related myopathy, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • hypokalemic periodic paralysis, type 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • potassium-aggravated myotonia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 16
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital myopathy
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital myopathy 22A, classic
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acetazolamide-responsive myotonia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia fluctuans
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia permanens
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 17-63971347-C-T is Benign according to our data. Variant chr17-63971347-C-T is described in ClinVar as Benign. ClinVar VariationId is 1265211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN4ANM_000334.4 linkc.612-94G>A intron_variant Intron 4 of 23 ENST00000435607.3 NP_000325.4 P35499

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN4AENST00000435607.3 linkc.612-94G>A intron_variant Intron 4 of 23 1 NM_000334.4 ENSP00000396320.1 P35499

Frequencies

GnomAD3 genomes
AF:
0.310
AC:
47003
AN:
151626
Hom.:
8259
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.149
Gnomad AMI
AF:
0.425
Gnomad AMR
AF:
0.270
Gnomad ASJ
AF:
0.404
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.363
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.405
Gnomad OTH
AF:
0.318
GnomAD4 exome
AF:
0.362
AC:
215373
AN:
595564
Hom.:
41065
AF XY:
0.360
AC XY:
113868
AN XY:
316676
show subpopulations
African (AFR)
AF:
0.146
AC:
2418
AN:
16580
American (AMR)
AF:
0.239
AC:
8114
AN:
33976
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
7582
AN:
19252
East Asian (EAS)
AF:
0.329
AC:
10478
AN:
31848
South Asian (SAS)
AF:
0.281
AC:
17271
AN:
61508
European-Finnish (FIN)
AF:
0.365
AC:
13017
AN:
35666
Middle Eastern (MID)
AF:
0.357
AC:
890
AN:
2492
European-Non Finnish (NFE)
AF:
0.398
AC:
144397
AN:
362852
Other (OTH)
AF:
0.357
AC:
11206
AN:
31390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
6280
12560
18841
25121
31401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1478
2956
4434
5912
7390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.310
AC:
47015
AN:
151746
Hom.:
8267
Cov.:
30
AF XY:
0.305
AC XY:
22643
AN XY:
74122
show subpopulations
African (AFR)
AF:
0.149
AC:
6175
AN:
41456
American (AMR)
AF:
0.270
AC:
4125
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.404
AC:
1397
AN:
3462
East Asian (EAS)
AF:
0.309
AC:
1586
AN:
5136
South Asian (SAS)
AF:
0.264
AC:
1270
AN:
4810
European-Finnish (FIN)
AF:
0.363
AC:
3821
AN:
10532
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.405
AC:
27470
AN:
67778
Other (OTH)
AF:
0.321
AC:
677
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1458
2916
4373
5831
7289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.370
Hom.:
14822
Bravo
AF:
0.297
Asia WGS
AF:
0.271
AC:
943
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.2
DANN
Benign
0.55
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2302237; hg19: chr17-62048707; API